JoVE Logo
Faculty Resource Center

Sign In

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

DOI :

10.3791/2345-v

10:29 min

November 12th, 2010

November 12th, 2010

38,798 Views

1Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, 2Neuronetics, Inc.

In this article, we examine the methodology and considerations relevant to the FDA approved depression treatment protocol using the Neuronetics NeuroStar TMS device.

Tags

NeuroStar TMS Device

-- Views

Related Videos

article

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

article

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

article

Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay

article

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method

article

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

article

Protocol for Isolating the Mouse Circle of Willis

article

A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains

article

A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

article

Using a Microfluidics Device for Mechanical Stimulation and High Resolution Imaging of C. elegans

article

A Protocol for Transcranial Photobiomodulation Therapy in Mice

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved